Lisata Therapeutics share price logo

Lisata Therapeutics

NASDAQ: LSTA

$1.02

-0.06

(-5.56%)

Live

as on

Lisata Therapeutics Stock Performance

as on October 15, 2026 at 4:07 am IST

  • Day's Low

    Day's High

    $1.01
    $1.07
    downward going graph

    0.98%

    Downside

    4.90%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.98
    $5.07
    downward going graph

    3.92%

    Downside

    397.06%

    Upside

    downward going graph

Lisata Therapeutics share price movements today

Previous Close
$1.08
Open
$1.01
Volume
52.5K
Market Cap
$9.5M
Day's Low - High
$1.01 - $1.07
52 Week Low - High
$0.98 - $5.07

Lisata Therapeutics Historical Returns

1 Month Return
-30.77 %
3 Month Return
-70.89 %
1 Year Return
-55.37 %
3 Year Return
-49.83 %
5 Year Return
0 %

Lisata Therapeutics Stock Fundamentals & Key Indicators

Check Lisata Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5M

EPS (TTM)

-1.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.64

Industry PE ratio

-2.35

PEG Ratio

-0.02

EBITDA

-16.0M

Revenue (TTM)

100.0K

Profit Margin

95.00%

Return On Equity TTM

-113.79%

Lisata Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lisata Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$9.5MNA-0.6495.00%0.00%
Neutral$85.3B-34.84%-28.20-12.57%0.00%
StrongBuy$128.5B166.75%29.4586.04%0.00%
Buy$78.5B35.55%17.8384.86%0.49%

Stock Returns calculator for Lisata Therapeutics Stock including INR - Dollar returns

The Lisata Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Lisata Therapeutics investment value today

Current value as on today

₹45,167

Returns

-₹54,833

(-54.83%)

Returns from Lisata Therapeutics Stock

-₹57,851 (-57.85%)

Dollar Impact

₹3,018 (+3.02%)

Analyst Recommendation on Lisata Therapeutics Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Lisata Therapeutics. Average target price of $4

Lisata Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Lisata Therapeutics.

What analysts predicted

74.5%UPSIDE

Target Price

$4

Current Price

$1.02

Analyzed by

9 Analysts

Target

$4.00

Lisata Therapeutics target price $4, a slight upside of 74.5% compared to current price of $1.02. According to 9 analysts rating.

Indian Investors' Interest in Lisata Therapeutics Stock

Search interest for Lisata Therapeutics Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-47% versus previous 30 day period

Lisata Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
1
-
0
-
0
-
-
Gross Profit
-
-
-
1
-
0
-
0
0
0
Operating Income
-6
-5
-5
-4
-5
-4
-4
-3
-4
-3
EBITDA
-6
-4
-4
-4
-5
-4
-4
-2
-4
-3
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-6
-5
-4
-4
-5
-4
-4
-2
-4
-2
Income Tax Expense
0
-
-
-
0
-
-
-
0
-
Net Income
-5
-5
-4
-4
-4
-4
-4
-2
-4
-2
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
0.00%
100.00%
0.00%
100.00%
0.00%
0.00%

Lisata Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
1
0
Gross Profit
0
0
0
0
-
-
-
1
0
Operating Income
-27
-16
-20
-19
-29
-57
-25
-22
-18
EBITDA
-27
-16
-20
-19
-28
-56
-22
-20
-17
Interest Expense
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-27
-16
-19
-19
-28
-56
-23
-20
-17
Income Tax Expense
-11
0
-
-10
-1
-2
-2
0
0
Net Income
22
-16
-20
-8
-27
-54
-20
-19
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
14.12%

Lisata Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-5
-4
-4
-4
-4
-4
-2
-4
-2
Operating Cash Flow
-7
-5
-2
-4
-5
-3
-3
-3
-3
-2
Investing Cash Flow
6
11
-6
1
9
0
5
-
-
-
Financing Cash Flow
0
0
-
0
0
0
0
0
0
0
Change in Cash
0
6
-8
-3
4
-3
2
-3
-2
-2

Lisata Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-16
-19
-8
-27
-54
-20
-19
-16
Operating Cash Flow
-20
-19
-18
-8
-22
-21
-20
-19
-15
Investing Cash Flow
41
-4
21
-7
-54
28
10
13
15
Financing Cash Flow
0
0
1
18
85
0
0
0
0
Change in Cash
19
-23
3
2
8
7
-9
-6
0

Global Institutional Holdings in Lisata Therapeutics

Check out the Institutions with significant holdings in Lisata Therapeutics.

Funds
Holdings
VANGUARD INDEX FUNDS
3.02%
Vanguard
3.02%
Fidelity Concord Street Trust
0.63%
Dimensional
0.00%
DFA
0.00%

Lisata Therapeutics News & Key Events

  • img

    Today's Timeline - 08 October

    Thu, 05:30 PM

    -

    Lisata Therapeutics granted U.S. patent for certepetide in treating pancreatic cancer and other solid tumors, expiring May 2041.

Insights on Lisata Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 723.8% return, outperforming this stock by 779.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 120.0% return, outperforming this stock by 169.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, LSTA stock has moved down by -30.8%

About Lisata Therapeutics

Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
OrganisationLisata Therapeutics
Headquarters110 Allen Road, Basking Ridge, NJ, 07920, US
IndustryBiotechnology
CEODavid J. Mazzo

Key Management of Lisata Therapeutics

Name

Title

Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.

CEO & Director

Mr. James Nisco

SVP of Finance and Treasury & Chief Accounting Officer

Dr. Joshua Lehrer-Graiwer FACC, M.D.

President & COO

FAQs

What is Lisata Therapeutics share price today?

Lisata Therapeutics share price today is $1.02 as on . Lisata Therapeutics share today touched a day high of $1.07 and a low of $1.01.

What is the 52 week high and 52 week low for Lisata Therapeutics share?

Lisata Therapeutics share touched a 52 week high of $5.07 on and a 52 week low of $0.98 on . Lisata Therapeutics stock price today i.e. is trending at $1.02,which is 79.88% down from its 52 week high and 4.08% up from its 52 week low.

What is Lisata Therapeutics's market capitalisation today?

Lisata Therapeutics market capitalisation is $0.00T as on .

How to invest in Lisata Therapeutics Stock (LSTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lisata Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Lisata Therapeutics Stock (LSTA) from India?

Indian investors can start investing in Lisata Therapeutics (LSTA) shares with as little as ₹95.13999938964844 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.40 in Lisata Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Lisata Therapeutics share’s latest price of $1.02 as on October 14, 2026 at 10:37 pm IST, you will get 9.8039 shares of Lisata Therapeutics. Learn more about fractional shares .